CG Oncology Inc. (CGON) vs Scholar Rock Holding Corporation (SRRK)
A side-by-side comparison of CG Oncology Inc. and Scholar Rock Holding Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGON
CG Oncology Inc.
$69.17HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
SRRK
Scholar Rock Holding Corporation
$43.59HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — CGON vs SRRK
growth of $100 · dividends reinvested · last 3yCGON +84.9% (+22.7%/yr)SRRK +194.4% (+43.3%/yr)SRRK compounded faster over this window
CGON SRRK
CGON vs SRRK: by the numbers
- •CGON is the larger company ($6.10B vs $5.22B market cap).
- •Both run net losses; SRRK's is the smaller (0.00% vs -3602.68% net margin).
Metrics side by side
Valuation
| Metric | CGON | SRRK |
|---|---|---|
| P/S ratio | 979.60 | N/A |
| P/B ratio | 5.93 | 20.58 |
Profitability
| Metric | CGON | SRRK |
|---|---|---|
| Gross margin | -15.02% | 0.00% |
| Operating margin | -4722.13% | 0.00% |
| Net margin | -3602.68% | 0.00% |
| ROE | -21.80% | -161.00% |
| ROIC | -24.33% | -90.04% |
Growth (annualized)
| Metric | CGON | SRRK |
|---|---|---|
| Total return CAGR (5Y) | N/A | 8.20% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.